Latest filing published 10 Mar 2026 for Encompass Health Corp, €1.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Edmund Fay in Encompass Health Corp, where the filings describe the role as chief executive. In total, 20 filings cover trades dated from 4 January 2016 to 9 March 2026.
Sales make up the whole of the open-market record (1 sale, €1.1M). Besides market trades, the filings include 18 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 10 March 2026, the filings show an open-market sale worth €1.1M in Encompass Health Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations